Clinical Trial: WATER IV PCa (AS Sub-study)

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07650448) titled 'WATER IV PCa (AS Sub-study)' on June 10.

Brief Summary: The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Localized Prostate Cancer

Intervention: DEVICE: Aquablation Therapy

The AquaBeam Robotic System and the HYDROS Robotic System utilize high-velocity sterile saline waterjet to resect prostate tissue, guided by real-time visualization through cystoscopy and transrectal ultrasound imaging. This minimally invasive surgical proc...